Logo

OYSTER POINT PHARMA, INC. 401(K) PLAN 401k Plan overview

Plan NameOYSTER POINT PHARMA, INC. 401(K) PLAN
Plan identification number 001

OYSTER POINT PHARMA, INC. 401(K) PLAN Benefits

401k Plan TypeDefined Contribution Pension
Plan Features/Benefits
  • Profit-sharing
  • ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
  • Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
  • Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
  • Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
  • Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
  • Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

OYSTER POINT PHARMA, INC. has sponsored the creation of one or more 401k plans.

Company Name:OYSTER POINT PHARMA, INC.
Employer identification number (EIN):811030955
NAIC Classification:325410

Form 5500 Filing Information

Submission information for form 5500 for 401k plan OYSTER POINT PHARMA, INC. 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
0012024-01-01
0012023-01-01
0012022-01-15

Plan Statistics for OYSTER POINT PHARMA, INC. 401(K) PLAN

401k plan membership statisitcs for OYSTER POINT PHARMA, INC. 401(K) PLAN

Measure Date Value
2024: OYSTER POINT PHARMA, INC. 401(K) PLAN 2024 401k membership
Total participants, beginning-of-year2024-01-01308
Total number of active participants reported on line 7a of the Form 55002024-01-010
Number of retired or separated participants receiving benefits2024-01-010
Number of other retired or separated participants entitled to future benefits2024-01-010
Total of all active and inactive participants2024-01-010
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2024-01-010
Total participants2024-01-010
Number of participants with account balances2024-01-010
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2024-01-010
2023: OYSTER POINT PHARMA, INC. 401(K) PLAN 2023 401k membership
Total participants, beginning-of-year2023-01-01297
Total number of active participants reported on line 7a of the Form 55002023-01-01240
Number of retired or separated participants receiving benefits2023-01-010
Number of other retired or separated participants entitled to future benefits2023-01-0168
Total of all active and inactive participants2023-01-01308
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2023-01-010
Total participants2023-01-01308
Number of participants with account balances2023-01-01261
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2023-01-010
2022: OYSTER POINT PHARMA, INC. 401(K) PLAN 2022 401k membership
Total participants, beginning-of-year2022-01-15283
Total number of active participants reported on line 7a of the Form 55002022-01-15250
Number of retired or separated participants receiving benefits2022-01-150
Number of other retired or separated participants entitled to future benefits2022-01-1547
Total of all active and inactive participants2022-01-15297
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2022-01-150
Total participants2022-01-15297
Number of participants with account balances2022-01-15249
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2022-01-150

Financial Data on OYSTER POINT PHARMA, INC. 401(K) PLAN

Measure Date Value
2024 : OYSTER POINT PHARMA, INC. 401(K) PLAN 2024 401k financial data
Total transfer of assets from this plan2024-02-29$16,369,222
Total income from all sources (including contributions)2024-02-29$529,380
Total of all expenses incurred2024-02-29$1,088,746
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2024-02-29$1,073,457
Value of total assets at end of year2024-02-29$0
Value of total assets at beginning of year2024-02-29$16,928,588
Total of administrative expenses incurred including professional, contract, advisory and management fees2024-02-29$15,289
Total interest from all sources2024-02-29$1,543
Total dividends received (eg from common stock, registered investment company shares)2024-02-29$2,421
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2024-02-29Yes
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan2024-02-29$0
Total dividends received from registered investment company shares (eg mutual funds)2024-02-29$2,421
Was this plan covered by a fidelity bond2024-02-29Yes
Value of fidelity bond cover2024-02-29$500,000
If this is an individual account plan, was there a blackout period2024-02-29No
Were there any nonexempt tranactions with any party-in-interest2024-02-29No
Assets. Loans (other than to participants) at end of year2024-02-29$0
Assets. Loans (other than to participants) at beginning of year2024-02-29$114,861
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2024-02-29No
Value of net income/loss2024-02-29$-559,366
Value of net assets at end of year (total assets less liabilities)2024-02-29$0
Value of net assets at beginning of year (total assets less liabilities)2024-02-29$16,928,588
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2024-02-29No
Were any loans by the plan or fixed income obligations due to the plan in default2024-02-29No
Were any leases to which the plan was party in default or uncollectible2024-02-29No
Value of interest in registered invesment companies (eg mutual funds) at end of year2024-02-29$0
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2024-02-29$16,813,727
Interest on participant loans2024-02-29$1,543
Net investment gain/loss from registered investment companies (e.g. mutual funds)2024-02-29$525,416
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2024-02-29No
Was there a failure to transmit to the plan any participant contributions2024-02-29No
Has the plan failed to provide any benefit when due under the plan2024-02-29No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2024-02-29$1,073,457
Did the plan have assets held for investment2024-02-29No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2024-02-29No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2024-02-29Yes
Opinion of an independent qualified public accountant for this plan2024-02-29Unqualified
Accountancy firm name2024-02-29SCHENIDER DOWNS & CO., INC.
Accountancy firm EIN2024-02-29251408703
2023 : OYSTER POINT PHARMA, INC. 401(K) PLAN 2023 401k financial data
Total income from all sources (including contributions)2023-12-31$9,100,179
Total of all expenses incurred2023-12-31$1,802,573
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2023-12-31$1,696,596
Total contributions o plan (from employers,participants, others, non cash contrinutions)2023-12-31$6,835,504
Value of total assets at end of year2023-12-31$16,928,588
Value of total assets at beginning of year2023-12-31$9,630,982
Total of administrative expenses incurred including professional, contract, advisory and management fees2023-12-31$105,977
Total interest from all sources2023-12-31$4,586
Total dividends received (eg from common stock, registered investment company shares)2023-12-31$556,619
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2023-12-31Yes
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan2023-12-31$0
Total dividends received from registered investment company shares (eg mutual funds)2023-12-31$556,619
Was this plan covered by a fidelity bond2023-12-31Yes
Value of fidelity bond cover2023-12-31$500,000
If this is an individual account plan, was there a blackout period2023-12-31No
Were there any nonexempt tranactions with any party-in-interest2023-12-31No
Contributions received from participants2023-12-31$3,693,772
Participant contributions at end of year2023-12-31$114,861
Participant contributions at beginning of year2023-12-31$87,157
Participant contributions at end of year2023-12-31$0
Participant contributions at beginning of year2023-12-31$74,138
Income. Received or receivable in cash from other sources (including rollovers)2023-12-31$1,543,567
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2023-12-31No
Value of net income/loss2023-12-31$7,297,606
Value of net assets at end of year (total assets less liabilities)2023-12-31$16,928,588
Value of net assets at beginning of year (total assets less liabilities)2023-12-31$9,630,982
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2023-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2023-12-31No
Were any leases to which the plan was party in default or uncollectible2023-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2023-12-31$16,813,727
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2023-12-31$9,438,763
Interest on participant loans2023-12-31$4,586
Net investment gain/loss from registered investment companies (e.g. mutual funds)2023-12-31$1,703,470
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2023-12-31No
Was there a failure to transmit to the plan any participant contributions2023-12-31No
Has the plan failed to provide any benefit when due under the plan2023-12-31No
Contributions received in cash from employer2023-12-31$1,598,165
Employer contributions (assets) at end of year2023-12-31$0
Employer contributions (assets) at beginning of year2023-12-31$30,924
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2023-12-31$1,696,596
Did the plan have assets held for investment2023-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2023-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2023-12-31No
2022 : OYSTER POINT PHARMA, INC. 401(K) PLAN 2022 401k financial data
Total transfer of assets to this plan2022-12-31$5,225,999
Total income from all sources (including contributions)2022-12-31$5,333,073
Total of all expenses incurred2022-12-31$928,090
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2022-12-31$856,187
Expenses. Certain deemed distributions of participant loans2022-12-31$28,046
Total contributions o plan (from employers,participants, others, non cash contrinutions)2022-12-31$5,871,790
Value of total assets at end of year2022-12-31$9,630,982
Value of total assets at beginning of year2022-12-31$0
Total of administrative expenses incurred including professional, contract, advisory and management fees2022-12-31$43,857
Total interest from all sources2022-12-31$2,729
Total dividends received (eg from common stock, registered investment company shares)2022-12-31$431,580
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2022-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2022-12-31$431,580
Was this plan covered by a fidelity bond2022-12-31Yes
Value of fidelity bond cover2022-12-31$500,000
If this is an individual account plan, was there a blackout period2022-12-31No
Were there any nonexempt tranactions with any party-in-interest2022-12-31No
Contributions received from participants2022-12-31$3,352,684
Participant contributions at end of year2022-12-31$87,157
Participant contributions at beginning of year2022-12-31$0
Participant contributions at end of year2022-12-31$74,138
Participant contributions at beginning of year2022-12-31$0
Income. Received or receivable in cash from other sources (including rollovers)2022-12-31$996,109
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Value of net income/loss2022-12-31$4,404,983
Value of net assets at end of year (total assets less liabilities)2022-12-31$9,630,982
Value of net assets at beginning of year (total assets less liabilities)2022-12-31$0
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2022-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2022-12-31No
Were any leases to which the plan was party in default or uncollectible2022-12-31No
Investment advisory and management fees2022-12-31$43,857
Value of interest in registered invesment companies (eg mutual funds) at end of year2022-12-31$9,438,763
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2022-12-31$0
Interest on participant loans2022-12-31$2,729
Net investment gain/loss from registered investment companies (e.g. mutual funds)2022-12-31$-973,026
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2022-12-31No
Was there a failure to transmit to the plan any participant contributions2022-12-31No
Has the plan failed to provide any benefit when due under the plan2022-12-31No
Contributions received in cash from employer2022-12-31$1,522,997
Employer contributions (assets) at end of year2022-12-31$30,924
Employer contributions (assets) at beginning of year2022-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2022-12-31$856,187
Did the plan have assets held for investment2022-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2022-12-31No
Opinion of an independent qualified public accountant for this plan2022-12-31Unqualified
Accountancy firm name2022-12-31SCHNEIDER DOWNS & CO., INC.
Accountancy firm EIN2022-12-31251408703

Form 5500 Responses for OYSTER POINT PHARMA, INC. 401(K) PLAN

2024: OYSTER POINT PHARMA, INC. 401(K) PLAN 2024 form 5500 responses
2024-01-01Type of plan entitySingle employer plan
2024-01-01This submission is the final filingYes
2024-01-01This return/report is a short plan year return/report (less than 12 months)Yes
2024-01-01Plan funding arrangement – TrustYes
2024-01-01Plan benefit arrangement - TrustYes
2023: OYSTER POINT PHARMA, INC. 401(K) PLAN 2023 form 5500 responses
2023-01-01Type of plan entitySingle employer plan
2023-01-01Plan funding arrangement – TrustYes
2023-01-01Plan benefit arrangement - TrustYes
2022: OYSTER POINT PHARMA, INC. 401(K) PLAN 2022 form 5500 responses
2022-01-15Type of plan entitySingle employer plan
2022-01-15First time form 5500 has been submittedYes
2022-01-15This return/report is a short plan year return/report (less than 12 months)Yes
2022-01-15Plan funding arrangement – TrustYes
2022-01-15Plan benefit arrangement - TrustYes

Potentially related plans

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
401k Lookup     VAT Lookup S1